40 per cent participants enrolled for COVID-19 vaccine trial: Moderna
Moderna began the study of its vaccine candidate, mRNA-1273, in July and expects to complete enrollment in September
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.